Clinical Trial Update: A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1 [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study to compare the pharmacokinetics and safety of BR2021 versus BR2021-1 in patients with metastatic pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BR2021
• BR2021-1

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Metastatic Adenocarcinoma of the Pancreas | Phase 1 | Status: RECRUITING